Inclusión de nuevas tecnologías en los sistemas de salud públicos en México: situación regulatoria

Abstract

One of the biggest challenges currently faced by Public Health Systems in Mexico is the decision making process about the potential inclusion of new health technologies. The aim of this work is to analyse the different tools that could help the decision-maker to optimise the benefits for the institution, as well as for the patients. This paper also focuses on the relevance of the role played by the oncologist, as an expert and advisor, in the decision making process. Finally, to fulfil the institution's requirements, it is suggested to consider the different type of uncertainties linked to the management of a public health care system in order to design innovative commercial agreements. These agreements provide access to high cost therapies without compromising the management of the institution.